10-K Filing

Astrana Health, Inc. CIK: 1083446 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001144204-18-018690`
Period End Date	20171231
Filing Date	20180402
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	ameh-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 98 Income Statement 58 Cash Flow Statement 116 Stockholders Equity 24

Balance Sheet 98 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.82M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$59.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$99.75M	USD	Point-in-time
Restricted cash - short-term	`RestrictedCashCurrent`	$18.01M	USD	Point-in-time
Restricted cash - short-term	`RestrictedCashCurrent`	$101.13K	USD	Point-in-time
Fiduciary cash	`AssetsHeldInTrustCurrent`	$2.02M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Fiduciary cash	`AssetsHeldInTrustCurrent`	$1.05M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.05M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.14M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$22.28M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$20.12M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	25.07M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	32.30M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.13M	USD	Point-in-time
Treasury Stock, Common, Shares	`TreasuryStockCommonShares`	1.68M	shares	Point-in-time
Treasury Stock, Common, Shares	`TreasuryStockCommonShares`	1.68M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.85M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$81.16M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$144.16M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.81M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.37M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$108.09M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$103.53M	USD	Point-in-time
Goodwill	`Goodwill`	$189.85M	USD	Point-in-time
Goodwill	`Goodwill`	$103.41M	USD	Point-in-time
Goodwill	`Goodwill`	$100.85M	USD	Point-in-time
Loans receivable - related parties	`DueFromRelatedPartiesNoncurrent`	$5.20M	USD	Point-in-time
Loans receivable - related parties	`DueFromRelatedPartiesNoncurrent`	$5.00M	USD	Point-in-time
Loan receivable	`LoansReceivableNet`	$10.00M	USD	Point-in-time
Loan receivable	`LoansReceivableNet`	-	USD	Point-in-time
Investments in other entities - equity method	`EquityMethodInvestments`	$24.26M	USD	Point-in-time
Investments in other entities - equity method	`EquityMethodInvestments`	$21.90M	USD	Point-in-time
Investments in other entities - cost method	`CostMethodInvestments`	-	USD	Point-in-time
Investments in other entities - cost method	`CostMethodInvestments`	$10.58M	USD	Point-in-time
Restricted cash - long-term	`RestrictedCashNoncurrent`	$745.24K	USD	Point-in-time
Restricted cash - long-term	`RestrictedCashNoncurrent`	-	USD	Point-in-time
Derivative asset - warrants	`DerivativeAssetsNoncurrent`	$5.34M	USD	Point-in-time
Derivative asset - warrants	`DerivativeAssetsNoncurrent`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.60M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.63M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$268.84M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$346.48M	USD	Point-in-time
Total assets	`Assets`	$490.64M	USD	Point-in-time
Total assets	`Assets`	$350.00M	USD	Point-in-time
Lines of credit	`LinesOfCreditCurrent`	-	USD	Point-in-time
Lines of credit	`LinesOfCreditCurrent`	$5.03M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$8.08M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$13.28M	USD	Point-in-time
Incentives payable	`IncentivePayableCurrent`	$21.50M	USD	Point-in-time
Incentives payable	`IncentivePayableCurrent`	$19.62M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$2.02M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$1.05M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$16.01M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$18.96M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$63.97M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$3.20M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.81M	USD	Point-in-time
Bank loan, short-term	`ShortTermBankLoansAndNotesPayable`	$510.39K	USD	Point-in-time
Bank loan, short-term	`ShortTermBankLoansAndNotesPayable`	-	USD	Point-in-time
Capital lease obligations	`CapitalLeaseObligationsCurrent`	$102.35K	USD	Point-in-time
Capital lease obligations	`CapitalLeaseObligationsCurrent`	$98.74K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$109.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$50.63M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$24.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$46.93M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$2.00M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Dividend payable	`DividendPayableNoncurrent`	$18.00M	USD	Point-in-time
Dividend payable	`DividendPayableNoncurrent`	-	USD	Point-in-time
Capital lease obligations, net of current portion	`CapitalLeaseObligationsNoncurrent`	-	USD	Point-in-time
Capital lease obligations, net of current portion	`CapitalLeaseObligationsNoncurrent`	$619.00K	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$44.72M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$48.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$99.56M	USD	Point-in-time
Total liabilities	`Liabilities`	$154.32M	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Pacific of California IPA	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$162.86M	USD	Point-in-time
Noncontrolling interest in Allied Pacific of California IPA	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$172.13M	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 32,304,876 and 25,067,953 shares outstanding, excluding 1,682,110 Treasury shares, at December 31, 2017 and 2016, respectively	`CommonStockValue`	$25.07K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 32,304,876 and 25,067,953 shares outstanding, excluding 1,682,110 Treasury shares, at December 31, 2017 and 2016, respectively	`CommonStockValue`	$32.30K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$87.95M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$158.18M	USD	Point-in-time
Retained earnings (accumulated deficit)	`RetainedEarningsAccumulatedDeficit`	$-773.31K	USD	Point-in-time
Retained earnings (accumulated deficit)	`RetainedEarningsAccumulatedDeficit`	$1.73M	USD	Point-in-time
Stockholders deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$87.21M	USD	Point-in-time
Stockholders deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$159.95M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$381.62K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.24M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$84.50M	USD	Point-in-time
Total liabilities, mezzanine equity and shareholders equity	`LiabilitiesAndStockholdersEquity`	$490.64M	USD	Point-in-time
Total liabilities, mezzanine equity and shareholders equity	`LiabilitiesAndStockholdersEquity`	$350.00M	USD	Point-in-time

Income Statement 58 line items

Line Item	Tag	Value	Unit	Period
Capitation, net	`HealthCareOrganizationCapitationRevenue`	$272.92M	USD	Annual
Capitation, net	`HealthCareOrganizationCapitationRevenue`	$247.64M	USD	Annual
Risk pool settlements and incentives	`HealthCareOrganizationOtherRevenue`	$22.64M	USD	Annual
Risk pool settlements and incentives	`HealthCareOrganizationOtherRevenue`	$44.60M	USD	Annual
Management fee income	`ManagementFeesRevenue`	$26.98M	USD	Annual
Management fee income	`ManagementFeesRevenue`	$24.77M	USD	Annual
Fee-for-service, net	`HealthCareOrganizationPatientServiceRevenue`	$11.71M	USD	Annual
Fee-for-service, net	`HealthCareOrganizationPatientServiceRevenue`	$9.16M	USD	Annual
Other income	`OtherSalesRevenueNet`	$1.71M	USD	Annual
Other income	`OtherSalesRevenueNet`	$1.53M	USD	Annual
Total revenue	`SalesRevenueNet`	$305.93M	USD	Annual
Total revenue	`SalesRevenueNet`	$357.75M	USD	Annual
Cost of services	`CostOfServices`	$254.77M	USD	Annual
Cost of services	`CostOfServices`	$274.66M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$21.03M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$26.44M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.08M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.11M	USD	Annual
Impairment of goodwill and intangibles	`GoodwillAndIntangibleAssetImpairment`	$324.31K	USD	Annual
Impairment of goodwill and intangibles	`GoodwillAndIntangibleAssetImpairment`	$2.43M	USD	Annual
Total expenses	`OperatingExpenses`	$322.60M	USD	Annual
Total expenses	`OperatingExpenses`	$294.25M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$11.69M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$35.15M	USD	Annual
(Loss) income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$4.75M	USD	Annual
(Loss) income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-1.11M	USD	Annual
Interest expense	`InterestExpense`	$79.69K	USD	Annual
Interest expense	`InterestExpense`	$61.59K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$504.70K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.02M	USD	Annual
Change in fair value of derivative instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$1.72M	USD	Annual
Change in fair value of derivative instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$-44.89K	USD	Annual
Gain on settlement of preexisting note receivable from ApolloMed	`GainLossOnSaleOfNotesReceivable`	$921.94K	USD	Annual
Gain on settlement of preexisting note receivable from ApolloMed	`GainLossOnSaleOfNotesReceivable`	-	USD	Annual
Gain from investments - fair value adjustments	`GainLossOnInvestments`	$13.70M	USD	Annual
Gain from investments - fair value adjustments	`GainLossOnInvestments`	-	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$233.73K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$168.10K	USD	Annual
Total other income, net	`NonoperatingIncomeExpense`	$7.15M	USD	Annual
Total other income, net	`NonoperatingIncomeExpense`	$14.57M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$49.71M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$18.84M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.89M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$8.82M	USD	Annual
Net income	`ProfitLoss`	$10.02M	USD	Annual
Net income	`ProfitLoss`	$45.82M	USD	Annual
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.43M	USD	Annual
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$20.02M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$11.45M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$25.80M	USD	Annual
Earnings per share - basic	`EarningsPerShareBasic`	$0.46	USD	Annual
Earnings per share - basic	`EarningsPerShareBasic`	$1.01	USD	Annual
Earnings per share - diluted	`EarningsPerShareDiluted`	$0.41	USD	Annual
Earnings per share - diluted	`EarningsPerShareDiluted`	$0.90	USD	Annual
Weighted average shares of common stock outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	24.67M	shares	Annual
Weighted average shares of common stock outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	25.53M	shares	Annual
Weighted average shares of common stock outstanding -diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.66M	shares	Annual
Weighted average shares of common stock outstanding -diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.97M	shares	Annual

Cash Flow Statement 116 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$10.02M	USD	Annual
Net income	`ProfitLoss`	$45.82M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.08M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.11M	USD	Annual
Impairment of goodwill and intangibles	`GoodwillAndIntangibleAssetImpairment`	$324.31K	USD	Annual
Impairment of goodwill and intangibles	`GoodwillAndIntangibleAssetImpairment`	$2.43M	USD	Annual
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$1.95M	USD	Annual
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$2.74M	USD	Annual
Unrealized gain from investment in equity securities	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Unrealized gain from investment in equity securities	`UnrealizedGainLossOnInvestments`	$86.00K	USD	Annual
Gain on settlement of preexisting note receivable from ApolloMed	`GainLossOnSaleOfNotesReceivable`	$921.94K	USD	Annual
Gain on settlement of preexisting note receivable from ApolloMed	`GainLossOnSaleOfNotesReceivable`	-	USD	Annual
Gain from investments - fair value adjustments	`GainLossOnInvestments`	$13.70M	USD	Annual
Gain from investments - fair value adjustments	`GainLossOnInvestments`	-	USD	Annual
Change in fair value of derivative instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$1.72M	USD	Annual
Change in fair value of derivative instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$-44.89K	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$4.75M	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-1.11M	USD	Annual
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$-20.68M	USD	Annual
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$-3.01M	USD	Annual
Change in restricted cash	`IncreaseDecreaseInRestrictedCash`	$-95.46K	USD	Annual
Change in restricted cash	`IncreaseDecreaseInRestrictedCash`	$756.00	USD	Annual
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-8.70M	USD	Annual
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-10.70M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-1.26M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$172.31K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$63.35K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$220.93K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-3.69M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.93M	USD	Annual
Capitation incentives payable	`IncreasedecreaseInCapitationIncentivesPayable`	$5.18M	USD	Annual
Capitation incentives payable	`IncreasedecreaseInCapitationIncentivesPayable`	$1.88M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$5.66M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$2.95M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-17.54M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$388.14K	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$51.93M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$21.91M	USD	Annual
Cash acquired in the Merger	`CashAcquiredFromAcquisition`	$36.37M	USD	Annual
Cash acquired in the Merger	`CashAcquiredFromAcquisition`	-	USD	Annual
Cash received from consolidation of VIE	`PaymentsForProceedsFromBusinessesAndInterestInAffiliates`	$-228.29K	USD	Annual
Cash received from consolidation of VIE	`PaymentsForProceedsFromBusinessesAndInterestInAffiliates`	-	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$10.45K	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$5.28K	USD	Annual
Restricted cash	`IncreaseInRestrictedCash`	$18.00M	USD	Annual
Restricted cash	`IncreaseInRestrictedCash`	-	USD	Annual
Proceeds from loans receivable	`ProceedsFromSaleOfLoansReceivable`	$200.00K	USD	Annual
Proceeds from loans receivable	`ProceedsFromSaleOfLoansReceivable`	-	USD	Annual
Advances on loans receivable	`PaymentsToAcquireLoansReceivable`	$10.00M	USD	Annual
Advances on loans receivable	`PaymentsToAcquireLoansReceivable`	-	USD	Annual
Advances to related parties - loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Advances to related parties - loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$200.00K	USD	Annual
Dividends received from equity method investments	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$1.24M	USD	Annual
Dividends received from equity method investments	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$2.00M	USD	Annual
Proceeds on sale of investments - cost method	`ProceedsFromSaleOfCostMethodInvestments`	-	USD	Annual
Proceeds on sale of investments - cost method	`ProceedsFromSaleOfCostMethodInvestments`	$25.00K	USD	Annual
Purchases of investments - cost method	`PaymentsToAcquireCostMethodInvestments`	$5.00M	USD	Annual
Purchases of investments - cost method	`PaymentsToAcquireCostMethodInvestments`	-	USD	Annual
Purchases of investments - equity method	`PaymentsToAcquireEquityMethodInvestments`	-	USD	Annual
Purchases of investments - equity method	`PaymentsToAcquireEquityMethodInvestments`	$2.44M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.08M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.31M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.96M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$7.97M	USD	Annual
Repayment of loan payable - related party	`RepaymentsOfRelatedPartyDebt`	$600.00K	USD	Annual
Repayment of loan payable - related party	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Dividends paid	`PaymentsOfDividends`	$10.45M	USD	Annual
Dividends paid	`PaymentsOfDividends`	$26.66M	USD	Annual
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	Annual
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	$1.12M	USD	Annual
Borrowings on line of credit	`ProceedsFromLinesOfCredit`	$5.00M	USD	Annual
Borrowings on line of credit	`ProceedsFromLinesOfCredit`	-	USD	Annual
Advances by NMM to ApolloMed prior to the Merger	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	Annual
Advances by NMM to ApolloMed prior to the Merger	`ProceedsFromPaymentsForOtherFinancingActivities`	$-9.00M	USD	Annual
Principal payments on bank loan	`RepaymentsOfBankDebt`	-	USD	Annual
Principal payments on bank loan	`RepaymentsOfBankDebt`	$1.48M	USD	Annual
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$102.35K	USD	Annual
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$181.01K	USD	Annual
Proceeds from exercise of stock options included in liabilities	`ProceedsFromStockOptionsExercisedIncludedInLiabilities`	$425.02K	USD	Annual
Proceeds from exercise of stock options included in liabilities	`ProceedsFromStockOptionsExercisedIncludedInLiabilities`	-	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$164.80K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$260.00K	USD	Annual
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$2.16M	USD	Annual
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$10.90M	USD	Annual
Repurchase of common shares	`PaymentsForRepurchaseOfCommonStock`	$3.18M	USD	Annual
Repurchase of common shares	`PaymentsForRepurchaseOfCommonStock`	$517.50K	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-17.15M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-14.98M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$44.92M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-4.19M	USD	Annual
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$54.82M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$59.01M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$99.75M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$54.82M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$59.01M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$99.75M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$24.36M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$29.37M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$61.59K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$51.04K	USD	Annual
Stock issued in connection with acquisitions	`StockIssued1`	$5.16M	USD	Annual
Stock issued in connection with acquisitions	`StockIssued1`	-	USD	Annual
Deferred tax liability adjusted to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	-	USD	Annual
Deferred tax liability adjusted to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$977.82K	USD	Annual
Equipment purchased with capital lease	`EquipmentPurchasedWithCapitalLease`	-	USD	Annual
Equipment purchased with capital lease	`EquipmentPurchasedWithCapitalLease`	$186.09K	USD	Annual
Dividends declared included in dividends payable and restricted cash	`DividendsDeclaredIncludedInDividendsPayableAndRestrictedCash`	-	USD	Annual
Dividends declared included in dividends payable and restricted cash	`DividendsDeclaredIncludedInDividendsPayableAndRestrictedCash`	$18.00M	USD	Annual
Distribution of warrants to former NMM shareholders	`AdjustmentOfWarrantsGrantedForServices`	-	USD	Annual
Distribution of warrants to former NMM shareholders	`AdjustmentOfWarrantsGrantedForServices`	$5.29M	USD	Annual
Issuance of common stock upon conversion of debt and accrued interest	`ConversionOfStockAmountIssued1`	-	USD	Annual
Issuance of common stock upon conversion of debt and accrued interest	`ConversionOfStockAmountIssued1`	$5.38M	USD	Annual
Reclassification of liability for unissued common shares payable to equity	`ReclassificationOfLiabilityForUnissuedCommonSharesPayableToEquity`	-	USD	Annual
Reclassification of liability for unissued common shares payable to equity	`ReclassificationOfLiabilityForUnissuedCommonSharesPayableToEquity`	$1.24M	USD	Annual
Reclassification of fiduciary cash to payable	`LiabilitiesAssumed1`	$966.70K	USD	Annual
Reclassification of fiduciary cash to payable	`LiabilitiesAssumed1`	$1.31M	USD	Annual

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.59M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$84.50M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$10.02M	USD	Annual
Net income (loss)	`ProfitLoss`	$45.82M	USD	Annual
Shares repurchased	`StockRepurchasedDuringPeriodValue`	$107.50K	USD	Annual
Shares repurchased	`StockRepurchasedDuringPeriodValue`	$1.65M	USD	Annual
Shares issued in connection with acquisitions	`StockIssuedDuringPeriodValueAcquisitions`	$5.16M	USD	Annual
Shares issued for cash and exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.06M	USD	Annual
Shares issued for cash and exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.02M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.93M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$596.19K	USD	Annual
Distribution of derivative assets - warrants	`AdjustmentOfWarrantsGrantedForServices`	-	USD	Annual
Distribution of derivative assets - warrants	`AdjustmentOfWarrantsGrantedForServices`	$5.29M	USD	Annual
Noncontrolling interest capital change	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$-110.00K	USD	Annual
Noncontrolling interest capital change	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$859.43K	USD	Annual
Dividends	`Dividends`	$20.91M	USD	Annual
Dividends	`Dividends`	$19.70M	USD	Annual
Reclassification of liability for unissued shares to equity	`StockIssuedDuringPeriodValueConversionOfLiabilityToEquity`	$1.24M	USD	Annual
Effect of share exchange in Merger	`StockIssuedDuringPeriodValueMerger`	$64.42M	USD	Annual
Shares issued upon conversion of Alliance Note	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$5.38M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$87.59M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$84.50M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.